Mode
Text Size
Log in / Sign up

Pre-eclampsia history associated with increased subclinical atherosclerosis markers in meta-analysisEarly Warning Signs: Pre-eclampsia Linked to Heart Risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider pre-eclampsia history as a potential marker for early vascular changes requiring cardiovascular risk assessment.

This systematic review and meta-analysis of 35 case-control studies examined the association between pre-eclampsia history and subclinical atherosclerosis markers in 20,235 women (3,376 with pre-eclampsia history). The analysis compared women with and without a history of pre-eclampsia, assessing carotid intima-media thickness (CIMT) and coronary artery calcium scoring (CAC) at various timepoints from pregnancy onward.

Women with pre-eclampsia history showed increased CIMT with a standardized mean difference of 0.63 (95% CI 0.32, 0.93). This difference was present during pregnancy (SMD 0.65, 95% CI 0.33, 0.98), persisted at 12 months postpartum (SMD 0.84, 95% CI 0.20, 1.47), and remained beyond 12 months (SMD 0.50, 95% CI 0.01, 0.99). For CAC, women with pre-eclampsia history had 1.57 times higher odds of subclinical atherosclerosis (95% CI 1.39, 1.77).

Safety data were not reported. Key limitations include the observational case-control design, which cannot establish causation, and lack of reported absolute numbers for clinical interpretation. The analysis focused on surrogate markers rather than clinical cardiovascular disease outcomes.

This evidence supports the importance of follow-up in patients with pre-eclampsia history but does not establish causation or guide specific interventions. The findings suggest pre-eclampsia may serve as a marker for identifying women who could benefit from cardiovascular risk assessment, though clinical management implications remain uncertain.

Many women feel safe once their baby is born. They think the hard part is over. But a new review shows the heart risk may have started earlier than we thought.

Pre-eclampsia is a serious condition that happens during pregnancy. It causes high blood pressure and protein in the urine. It can make a mother feel very sick.

Doctors know these women are at higher risk for heart disease later. But we do not have clear rules on when to check them. Many women wait years before getting tested. This delay might let problems grow silently.

The surprising shift

For a long time, doctors waited until years after birth to screen for heart issues. We assumed the body would heal itself quickly. But this study changes that view.

But here is the twist. The signs of heart trouble appear right during pregnancy. They stay there for months and even years after delivery. Waiting to check a woman's heart health might be too late.

What scientists didn't expect

Think of your arteries like garden hoses. Over time, they can get clogged with plaque. This is called atherosclerosis. It happens slowly and often without pain.

In women with pre-eclampsia, these hoses get clogged faster. The study looked at three types of checks. One measures the thickness of the neck arteries. Another looks for calcium in the heart arteries. The third checks blood pressure in the legs.

All three methods showed the same thing. Women with this pregnancy complication had thicker artery walls. They also had more calcium buildup. This means the damage starts early and lasts a long time.

The study in simple terms

Researchers looked at 35 different studies. Together, they included over 20,000 women. About 3,400 of these women had pre-eclampsia.

The team compared women with the condition to those without it. They used special tests to look for hidden heart disease. These tests are standard in cardiology clinics today.

The results were clear and consistent. Women with pre-eclampsia had thicker artery walls during pregnancy. The difference was noticeable even before the baby was born.

This extra thickness did not go away quickly. It stayed high for 12 months after birth. It remained elevated for years in many cases. The risk of having calcium buildup in the heart arteries was also much higher.

This doesn't mean this treatment is available yet.

The study does not offer a new drug. It offers a new plan for checking patients. Doctors should consider testing these women sooner. Early detection allows for better lifestyle changes or medication.

If you had pre-eclampsia, talk to your doctor about heart checks. Do not wait for symptoms to appear. Heart disease often has no warning signs until it is serious.

You can lower your risk with healthy habits. Eat well, move your body, and manage stress. But knowing your status is the first step. Ask your provider if you need a screening now.

The limitations

This review combined data from many studies. Some studies were small. Most looked at women in specific regions. We do not know if results apply to every single person.

Also, these are observational findings. They show a link, not a cause. We cannot say the condition caused the heart issue directly. But the connection is strong enough to worry about.

Doctors will likely update their guidelines soon. We may see new recommendations for routine screening. These checks could become standard care for women with this history.

More research will follow. Scientists want to find the best time for testing. They also want to know which women need the most help. The goal is to keep women healthy for life.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up12.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Women with pre-eclampsia are at increased risk of later-life cardiovascular disease (CVD). Despite suggestions that women affected by pre-eclampsia should undergo routine CVD screening, uniform recommendations are lacking. Subclinical atherosclerosis provides a window of opportunity to identify and treat those at risk of CVD. Coronary artery calcium scoring (CAC), carotid intima-media thickness (CIMT) and ankle brachial index (ABI) are effective methods of detecting subclinical atherosclerosis. This systematic review sought to explore associations between timing of measurement and presence of subclinical atherosclerosis in women with a history of pre-eclampsia. METHODS: We searched the MEDLINE, EMBASE and CINAHL databases for all studies which reported subclinical atherosclerosis in women with a history of pre-eclampsia. Common and random effects models were used to examine the associations between pre-eclampsia and subclinical atherosclerosis. RESULTS: 35 case-control studies comprising 20 235 women were included in the final analysis. 3376 had a history of pre-eclampsia. Among the 26 studies assessing CIMT, pre-eclampsia was associated with increased CIMT (standardised mean difference 0.63 (95% CI 0.32, 0.93)). This difference was present during pregnancy (0.65 (95% CI 0.33, 0.98)) and persisted for 12 months post partum (0.84 (95% CI 0.20, 1.47)) and beyond (0.50 (95% CI 0.01, 0.99)). Pooled analysis of the eight CAC studies also demonstrated that the odds of having subclinical atherosclerosis were 1.57 (95% CI 1.39, 1.77) times higher in women with a history of pre-eclampsia. CONCLUSIONS: Among women with a history of pre-eclampsia, subclinical atherosclerosis can be seen during pregnancy and persists long term. Our review supports the importance of early follow-up in patients who have had pre-eclampsia.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.